BioScrip (BIOS) Misses Q4 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
Go back to BioScrip (BIOS) Misses Q4 EPS by 5c
March 2, 2016 4:30 PM EST
Q4 Consolidated Adjusted EBITDA of $9.0 Million
Reaffirms 2016 Adjusted EBITDA Guidance of Between $50 Million - $60 Million
DENVER, March 02, 2016 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ: BIOS) (BioScrip or the Company) today announced financial results for the fourth quarter and full year 2015. For the fourth quarter, the Company reported revenue from continuing operations of $243.8 million, net loss from continuing operations of ($19.1) million and diluted EPS of ($0.28) loss per share. Excluding restructuring costs, the Company reported normalized net loss from continuing operations for the quarter of ($9.2) million and normalized diluted EPS of ($0.13) loss per share.                               ... More
